- The company performed tests on mice and found the drug to be effective in inhibiting cell growth
- The cure will be effective from the first day and will last a few weeks without side effects
- However, the company will have to test the drug on human beings before its allowed into the market
An Israeli biotechnology company has said it will have a dosage that targets and kills cancer cells in human body in the next one year.
According to Accelerated Evolution Biotechnologies (AEBi), preliminary research and testing on mice using peptides made out of a chain of amino acids yielded positive results after inhibiting cell growth and had no effect on healthy mice cells.
READ ALSO: Why we ruled against Onnoghen's suit - Appeal Court opens up
Despite the promising scientific breakthrough, the company will still have to test the drug for years before being allowed into the market, as reported by CNBC.
"We believe we will offer in a year's time a complete cure for cancer," said the company's Chairman of the Board of Directors, Dan Aridor
"Our cancer cure will be effective from day one, will last a few weeks and will have none or minimal side-effects at a much lower cost than most treatments in the market,” he added.
The company will be required to perform scientific tests on human beings to find out if it inhibits cancer cell growth and if it has a real heath benefit before it's approved for roll out into the market.
PAY ATTENTION: Get the Latest Nigerian News on Legit.ng News App
Meanwhile, Legit.ng previously reported that the music legend James Ingram had passed on after suffering from brain cancer.
The 66-year-old Grammy Award winner was believed to have battled with the illness for a long period of time before eventually giving up the fight.
Ingram, up until his death, was considered one of the most talented soul music legends to ever come out of America.
Nigeria Latest News: Women Lead Walk for Cancer Awareness | Legit TV